Nicole M. Mcfarlane
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Journal: Cell stem cell
Published: March 28, 2019
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Journal: Journal of neuro-oncology
Published: October 09, 2018
Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis.
Journal: Cancer research
Published: April 05, 2018
BMI1 is a therapeutic target in recurrent medulloblastoma.
Journal: Oncogene
Published: February 20, 2018
RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
Journal: Acta neuropathologica
Published: May 03, 2017
The identification of human pituitary adenoma-initiating cells.
Journal: Acta neuropathologica communications
Published: November 16, 2016
Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2016
Culture and Isolation of Brain Tumor Initiating Cells.
Journal: Current protocols in stem cell biology
Published: August 04, 2015
A novel stem cell culture model of recurrent glioblastoma.
Journal: Journal of neuro-oncology
Published: March 05, 2015
Last Updated: 09/26/2026